Ronald Blue Trust, Inc. Mesoblast LTD Transaction History

Ronald Blue Trust, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$1.0 - $1.39 $1,163 - $1,616	1,163 New	1,163 $1,000
Q2 2023 Jul 14, 2023	SELL	$2.95 - $4.44 $728 - $1,096	-247 Reduced 94.27%	15 $0
Q1 2023 Apr 17, 2023	SELL	$2.94 - $4.18 $2,334 - $3,318	-794 Reduced 75.19%	262 $1,000
Q4 2022 Jan 17, 2023	BUY	$2.73 - $3.7 $701 - $950	257 Added 32.17%	1,056 $3,000
Q3 2022 Oct 21, 2022	BUY	$0.48 - $3.48 $383 - $2,780	799 New	799 $2,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

Stay updated on Ronald Blue Trust, Inc. with notifications on news.